chr14-102428245-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_014844.5(TECPR2):​c.952-5G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 0 hom., cov: 0)
Exomes 𝑓: 0.13 ( 22 hom. )
Failed GnomAD Quality Control

Consequence

TECPR2
NM_014844.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00004718
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.377

Publications

0 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 14-102428245-G-T is Benign according to our data. Variant chr14-102428245-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 702193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECPR2NM_014844.5 linkc.952-5G>T splice_region_variant, intron_variant Intron 6 of 19 ENST00000359520.12 NP_055659.2 O15040-1
TECPR2NM_001172631.3 linkc.952-5G>T splice_region_variant, intron_variant Intron 6 of 16 NP_001166102.1 O15040-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECPR2ENST00000359520.12 linkc.952-5G>T splice_region_variant, intron_variant Intron 6 of 19 1 NM_014844.5 ENSP00000352510.7 O15040-1
TECPR2ENST00000558678.1 linkc.952-5G>T splice_region_variant, intron_variant Intron 6 of 16 1 ENSP00000453671.1 O15040-2

Frequencies

GnomAD3 genomes
AF:
0.0393
AC:
1020
AN:
25938
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0388
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0294
Gnomad ASJ
AF:
0.0313
Gnomad EAS
AF:
0.0215
Gnomad SAS
AF:
0.0511
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0453
Gnomad OTH
AF:
0.0328
GnomAD2 exomes
AF:
0.00449
AC:
98
AN:
21844
AF XY:
0.00434
show subpopulations
Gnomad AFR exome
AF:
0.00692
Gnomad AMR exome
AF:
0.0145
Gnomad ASJ exome
AF:
0.00279
Gnomad EAS exome
AF:
0.00672
Gnomad FIN exome
AF:
0.000935
Gnomad NFE exome
AF:
0.00280
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.132
AC:
62206
AN:
472908
Hom.:
22
Cov.:
17
AF XY:
0.128
AC XY:
29602
AN XY:
231568
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.104
AC:
1088
AN:
10422
American (AMR)
AF:
0.0226
AC:
154
AN:
6802
Ashkenazi Jewish (ASJ)
AF:
0.0527
AC:
465
AN:
8822
East Asian (EAS)
AF:
0.0124
AC:
228
AN:
18366
South Asian (SAS)
AF:
0.150
AC:
1961
AN:
13046
European-Finnish (FIN)
AF:
0.00997
AC:
217
AN:
21768
Middle Eastern (MID)
AF:
0.0848
AC:
144
AN:
1698
European-Non Finnish (NFE)
AF:
0.151
AC:
55831
AN:
370522
Other (OTH)
AF:
0.0987
AC:
2118
AN:
21462
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.281
Heterozygous variant carriers
0
5743
11487
17230
22974
28717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2874
5748
8622
11496
14370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0393
AC:
1020
AN:
25954
Hom.:
0
Cov.:
0
AF XY:
0.0359
AC XY:
449
AN XY:
12498
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0386
AC:
272
AN:
7040
American (AMR)
AF:
0.0293
AC:
68
AN:
2320
Ashkenazi Jewish (ASJ)
AF:
0.0313
AC:
20
AN:
638
East Asian (EAS)
AF:
0.0217
AC:
24
AN:
1106
South Asian (SAS)
AF:
0.0519
AC:
47
AN:
906
European-Finnish (FIN)
AF:
0.0135
AC:
14
AN:
1034
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
28
European-Non Finnish (NFE)
AF:
0.0453
AC:
559
AN:
12340
Other (OTH)
AF:
0.0319
AC:
12
AN:
376
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.350
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia 49 Benign:1
Feb 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
6.9
DANN
Benign
0.76
PhyloP100
-0.38
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000047
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55716270; hg19: chr14-102894582; API